Loading...
*  THE NATIONAL HOME INFUSION ASSOCIATION: Infusion Magazine - Archives
Counce J and Jurich S. Alternate-site infusion provider roundtable: A discussion of urgency-Why active grassroots is key to ... NHIA raises concerns on proposed Medicare policies for home parenteral nutrition. 1995;1(11):28-36. Rigas M. 340B drug pricing ... Our Current Issue Subscribe to INFUSION Author Guidelines Advertise in INFUSION Archives Faces Behind-the-Scenes CE Infusion ... Home infusion coding and claiming: Big changes are in the works. 2000;7(1):40-1. Kaplan LK. HIPAA, HIEC, and home infusion ...
  http://www.nhia.org/infusion/archives/regulatory.cfm
*  SODIUM CHLORIDE 0.18% AND GLUCOSE 4% INFUSION BP POLYFUSOR AS STERIFLEX NO. 18 OR FREEFLEX | Drugs.com
INFUSION BP POLYFUSOR AS STERIFLEX NO. 18 OR FREEFLEX Including dosage instructions and possible side effects. ... Active substance(s): GLUCOSE MONOHYDRATE FOR PARENTERAL USE / SODIUM CHLORIDE INJECTION. PDF options: View Fullscreen Download ... active ingredient can be seen in the name of product.. Sodium Chloride 0.9% and. Glucose 5% Solution for Infusion. What Sodium ... Infusion or you are given your infusion too quickly, this may lead to the following symptoms:. • water and/or sodium overload ...
  https://www.drugs.com/uk/sodium-chloride-0-18-and-glucose-4-infusion-bp-polyfusor-as-steriflex-no-18-or-freeflex-leaflet.html
*  Patent US7652001 - Pharmacologically active agents containing esterified phosphonates and ... - Google Patents
The percentage of active compound contained in such parenteral compositions is highly dependent on the specific nature thereof ... Illustratively, intravenous or intraarterial infusion of a sterile aqueous solution containing an active compound is an ... The active materials can also be mixed with other active materials which do not impair the desired action, or with materials ... To produce a prodrug, the pharmaceutically active compound is modified such that the active compound will be regenerated by ...
  http://www.google.com/patents/US7652001?dq=Xerox+%2B+%22centroid
*  Systemic administration of Hypocretin-1 - The Regents of the University of California
Hcrt-1 and other active agents of the invention can be formulated for parenteral administration by injection, e.g., by bolus ... The method of claim 6, wherein the dosage regime is administered by intravenous infusion. 14. The method of claim 6, wherein ... Pharmaceutical formulations for parenteral administration include aqueous solutions of the active compounds in water-soluble ... Alternatively, the active ingredient can be in powder form for constitution with a suitable vehicle, e.g., sterile pyrogen-free ...
  http://www.freepatentsonline.com/7112566.html
*  Active principle | definition of active principle by Medical dictionary
... active principle explanation free. What is active principle? Meaning of active principle medical term. What does active ... Looking for online definition of active principle in the Medical Dictionary? ... is a potent dopamine agonist which in its parenteral forms (transdermal patch and sc infusion) has been developed to provide ... active. not passive.. active principle. the drugs or chemicals in a pharmaceutical preparation that exert an effect ...
  http://medical-dictionary.thefreedictionary.com/active+principle
*  https://www.medicalnewstoday.com/releases/110022.php
Lisuride, the active principle of Nenad(R), is a potent dopamine agonist which in its parenteral forms (transdermal patch and ... Lisuride sc (Nenad(R) Powder for solution for sc infusion) was developed for the treatment of patients in an advanced stage of ... The continuous application of this parenteral dopamine agonist using a small portable minipump provides stable individual drug ... AG, A. (2008, June 5). "EMEA Application For Nenad(R) (lisuride) Transdermal Patch And Subcutaneous Infusion For Parkinson's ...
  https://www.medicalnewstoday.com/releases/110022.php
*  Patente US7097827 - Devices, compositions and methods for the pulmonary delivery of aerosolized ... - Google Patentes
Suggested administration routes include parenteral by injection, rapid infusion, nasopharyngeal absorption, dermal absorption, ... Josic, Djuro, "Optimization of Process Conditions for the Production of Active Dry Yeast," Lebensm-Wiss, U. Technol., 1982, vol ... Townsend, Michael et al., "Use of Lyoprotectants in The Freez-Drying of a Model Protein Rebonuclease A," Journal of Parenteral ... Composition and method for administration of pharmaceutically active substances. US5017372. 19 Oct 1988. 21 May 1991. Medicis ...
  http://www.google.es/patents/US7097827?hl=es
*  Excipients for injectables and dialysis: providing excipients and active pharmaceutical ingredients | Roquette
In Large Volume Parenteral (LVP) and Total Parenteral Nutrition (TPN) *LYCADEX® PF pyrogen free monohydrate dextrose ... analysis of purity and filterability is performed to ensure that high quality standards required for dialysis and infusion ... of parenteral preparations are looking for reliable suppliers who have a range of the highest purity excipients and active ...
  https://www.roquette.com/pharma/injectable-and-dialysis/
*  Use of NPSP558 in the Treatment of Hypoparathyroidism - Full Text View - ClinicalTrials.gov
Patients dependent on regular parenteral calcium infusions (eg calcium gluconate) to maintain calcium homeostasis ... Subjects Who Achieved Independence from Active Vitamin D Usage and with Calcium Dose of 500 mg/day or less. This analysis was ... Proportion of Subjects Who Achieved Independence From Active Vitamin D and an Oral Calcium Dose of ≤ 500 mg/Day at Week 24. [ ... Patients that have undergone gastric resection or have active peptic ulcer disease requiring medical therapy ...
  https://clinicaltrials.gov/ct2/show/study/NCT00732615
*  Cimetidine Injection - FDA prescribing information, side effects and uses
In a crossover study involving patients with active or healed duodenal or gastric ulcers, either continuous I.V. infusion of ... Recommendations for Parenteral Administration:. Intramuscular Injection: 300 mg every 6 to 8 hours (no dilution necessary). ... Active Benign Gastric Ulcer. Cimetidine has been shown to be effective in the short-term treatment of active benign gastric ... Active Benign Gastric Ulcer. The recommended adult oral dosage for short-term treatment of active benign gastric ulcer is 800 ...
  https://www.drugs.com/pro/cimetidine-injection.html
*  Methods for detecting and treating cancer - The General Hospital Corporation
Alternatively, the active drug may be incorporated in biocompatible carriers, liposomes, nanoparticles, implants, or infusion ... Parenteral Compositions. The pharmaceutical composition may be administered parenterally by injection, infusion or implantation ... In one example, the first active anti-neoplasia therapeutic is contained on the inside of the tablet, and the second active ... Controlled Release Parenteral Compositions. Controlled release parenteral compositions may be in form of aqueous suspensions, ...
  http://www.freepatentsonline.com/9885720.html
*  2011 Oley Award and Scholarship Winners - Oley Foundation
Laurie is active with the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) and the National Home Infusion ... Matisse is active in her school and once took on a project to collect extra Halloween candy to distribute to other children. ... Hardy, who is also active with PN-DU. Karen Winterbourn, who has known Brenda since 2009, says, "I have been amazed at Brenda's ... Brenda is a real presence in online support groups (such as Yahoo groups) and on the fairly new Parenteral Nutrition-Down Under ...
  http://oley.org/page/2011_Award_Winners/2011-Oley-Award-and-Scholarship-Winners.htm
*  US Patent # 4,119,717. 16-S-acyl derivatives of fusidic acid - Patents.com
For parenteral use the compounds are preferably given by intravenous infusion of an aqueous solution containing from 0.1 to 2 ... A preparation as claimed in claim 15 wherein the dosage unit contains from 0.2 g to 0.75 g of at least one active compound. 17 ... A parenteral pharmaceutical preparation in dosage unit form, containing from 0.05 g to 1 g of at least one compound according ... The parenteral preparations are in particular useful in the treatment of conditions in which a quick response to the treatment ...
  http://patents.com/us-4119717.html
*  Patent US6147109 - Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA ... - Google Patents
The term "parenteral" includes subcutaneous, intravenous, intramuscular, or infusion. Intravenous or intramuscular routes are ... Generally, doses of active compounds would be from about 0.01 mg/kg per day to 1000 mg/kg per day. It is expected that doses ... Physiologically active substances. US4231938 *. Jun 15, 1979. Nov 4, 1980. Merck & Co., Inc.. Hypocholesteremic fermentation ... Specific examples include, but are not limited to: (a) erosional systems in which the active compound is contained in a form ...
  http://www.google.com/patents/US6147109?dq=%22robert+sheehan%22
*  Patent US6180597 - Upregulation of Type III endothelial cell nitric oxide synthase by rho ... - Google Patents
The term "parenteral" includes subcutaneous, intravenous, intramuscular, or infusion. Intravenous or intramuscular routes are ... displaces an active protein from its interaction with the cellular machinery or competes with the active protein, thereby ... Generally, doses of active compounds would be from about 0.01 mg/kg per day to 1000 mg/kg per day. It is expected that doses ... Infusion Pumps and Methods for Use. US20070270581 *. 16 Nov 2005. 22 Nov 2007. Biomarin Pharmaceutical Inc.. Stable Tablet ...
  http://www.google.ca/patents/US6180597
*  Patent US6492130 - Modulation of the sulfonylurea receptor and calcium in adipocytes for ... - Google Patents
... including parenteral, intranasal, intrapulmonar, oral, topical, anal or surgical implantation or insertion. Typical parenteral ... The pharmaceutically active agent can also be formulated in a sustained-release form to prolong the presence of the ... intraarterial and intraperitoneal injection or infusion. Preferably the administration is by injection. In preferred ... When pharmaceutically active agents are proteins, storage can be facilitated by drying processes, such as lyophilization. ...
  http://www.google.com/patents/US6492130?dq=6,123,819
*  Patent US8153162 - Purified amniotic membrane compositions and methods of use - Google Patents
Parenteral injections may involve bolus injection or continuous infusion. Formulations for injection may be presented in unit ... Pharmaceutical formulations for parenteral administration include aqueous solutions of the active compounds in water soluble ... Parenteral Composition. A parenteral composition for intramuscular administration is prepared by mixing 10 mg each of: HA, TSG- ... Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration ...
  http://www.google.com/patents/US8153162?dq=7751826
*  US5312828A - Substituted imidazoles having angiotensin II receptor blocking activity - Google Patents
... or continuously by infusion. Oral dosage units for human administration preferably contain from 10 to 500 mg of active compound ... Preferably, lower dosages are used for parenteral administration. Oral administration, at higher dosages, however, also can be ... As a topical dosage unit form, an amount of active compound from between 50 ng to 0.05 mg, preferably 50 ng to 5 mg, is applied ... Topical formulations contain the active compound in an amount selected from 0.0001 to 0.1 (w/v%), preferably from 0.0001 to ...
  https://patents.google.com/patent/US5312828A/en
*  Patent US4532331 - 1-Benzyl-2-aminomethyl imidazole derivatives - Google Patents
... by injection or by infusion. Parenteral administration, which uses a low dose is preferred. However, oral administration, at a ... In addition to decreasing hypertension, inhibitors of NE synthesis are active as diuretics, natriuretics, cardiotonics and ... a nontoxic quantity selected from the range of 0.1-1,000 mg/kg of active compound, preferably 10-100 mg/kg. The selected dose ... to give the desired oral or parenteral end products. ...
  http://www.google.com/patents/US4532331?dq=6,970,917
*  Parenteral anesthesia | definition of parenteral anesthesia by Medical dictionary
What is parenteral anesthesia? Meaning of parenteral anesthesia medical term. What does parenteral anesthesia mean? ... Looking for online definition of parenteral anesthesia in the Medical Dictionary? parenteral anesthesia explanation free. ... Before nerve block anesthesia, an intravenous infusion is established to ensure hydration. The patient is protected with side ... The temperatures of elderly patients should be monitored, heat loss prevented, and, as necessary, active rewarming provided. ...
  https://medical-dictionary.thefreedictionary.com/parenteral+anesthesia
*  Application # 2017/0049777. COMPOSITIONS, METHODS AND USES FOR THE TREATMENT OF DIABETIC NEUROPATHIES - Patents.com
Parenteral Compositions [0153] The pharmaceutical composition may also be administered parenterally by injection, infusion or ... active compound. Usually, the prodrug is devoid of activity or less active than the drug and the drug is released from the ... 0154] Compositions for parenteral use may be provided in unit dosage forms (e.g., in single-dose ampoules), or in vials ... Apart from the active drug(s), the composition may include suitable parenterally acceptable carriers and/or excipients. The ...
  http://patents.com/us-20170049777.html
*  US Patent # 9,670,198. Nicotinic acetylcholine receptor modulators - Patents.com
The percentage of active compound contained in such parenteral compositions is highly dependent on the specific nature thereof ... Illustratively, intravenous or intraarterial infusion of a sterile aqueous solution containing an active compound is an ... The percentage of active ingredient contained in such parenteral compositions is highly dependent on the specific nature ... The active materials can also be mixed with other active materials which do not impair the desired action, or with materials ...
  http://patents.com/us-9670198.html
*  Methods for treating hypertension, angina, and congestive heart failure using of optically pure (-) amlodipine - Sepracor Inc.
... oral or parenteral (including intravenous injections or infusions). In preparing the compositions for oral dosage form any of ... The active compound of this composition and method is an optical isomer of the compound amlodipine, which is described in ... In describing an optically active compound, the prefixes D and L or R and S are used to denote the absolute configuration of ... The authors allege that in vitro evaluation of the enantiomers of amlodipine shows the (−) isomer to be twice as active as the ...
  http://www.freepatentsonline.com/6753338.html
*  Benzoxazepine compounds, their preparation and use - Patent # 8263587 - PatentGenius
... formulations of the present invention may be formulated for parenteral administration by injection or continuous infusion. ... An active compound would decrease the amount of glucose formed, which is read at 520 nm by glucose oxidase-peroxidase method.. ... Alternatively, the active ingredient may be in powder form for constitution with a suitable vehicle (e.g.,sterile, pyrogen-free ... The formulations according to the invention may contain between 0.1-99% of the active ingredient, conveniently from 30-95% for ...
  http://www.patentgenius.com/patent/8263587.html
*  A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
No active systemic infection requiring parenteral antibiotic therapy. - No history of or presence of a CNS disease. - No ... No major surgery or open biopsy within 28 days before drug infusion or evidence of. active bleeding postoperatively. - No plan ... non-aspirin NSAID within 48 hours following study treatment infusion. Other. - ...
  http://www.knowcancer.com/cancer-trials/NCT01325558/